197 related articles for article (PubMed ID: 37967663)
21. Association of Neurofilament Light Chain, [
Palleis C; Franzmeier N; Weidinger E; Bernhardt AM; Katzdobler S; Wall S; Ferschmann C; Harris S; Schmitt J; Schuster S; Gnörich J; Finze A; Biechele G; Lindner S; Albert NL; Bartenstein P; Sabri O; Barthel H; Rupprecht R; Nuscher B; Stephens AW; Rauchmann BS; Perneczky R; Haass C; Brendel M; Levin J; Höglinger GU
Neurology; 2024 Jan; 102(1):e207901. PubMed ID: 38165362
[TBL] [Abstract][Full Text] [Related]
22. Associations of plasma phosphorylated tau181 and neurofilament light chain with brain amyloid burden and cognition in objectively defined subtle cognitive decline patients.
Huang Y; Li Y; Xie F; Guo Q
CNS Neurosci Ther; 2022 Dec; 28(12):2195-2205. PubMed ID: 36074638
[TBL] [Abstract][Full Text] [Related]
23. Axonal degeneration and amyloid pathology predict cognitive decline beyond cortical atrophy.
Svenningsson AL; Stomrud E; Palmqvist S; Hansson O; Ossenkoppele R
Alzheimers Res Ther; 2022 Oct; 14(1):144. PubMed ID: 36192766
[TBL] [Abstract][Full Text] [Related]
24. Cerebrospinal fluid GFAP is a predictive biomarker for conversion to dementia and Alzheimer's disease-associated biomarkers alterations among de novo Parkinson's disease patients: a prospective cohort study.
Liu T; Zuo H; Ma D; Song D; Zhao Y; Cheng O
J Neuroinflammation; 2023 Jul; 20(1):167. PubMed ID: 37475029
[TBL] [Abstract][Full Text] [Related]
25. Blood biomarkers of traumatic brain injury and cognitive impairment in older veterans.
Peltz CB; Kenney K; Gill J; Diaz-Arrastia R; Gardner RC; Yaffe K
Neurology; 2020 Sep; 95(9):e1126-e1133. PubMed ID: 32571850
[TBL] [Abstract][Full Text] [Related]
26. Comparison of plasma neurofilament light and total tau as neurodegeneration markers: associations with cognitive and neuroimaging outcomes.
Marks JD; Syrjanen JA; Graff-Radford J; Petersen RC; Machulda MM; Campbell MR; Algeciras-Schimnich A; Lowe V; Knopman DS; Jack CR; Vemuri P; Mielke MM;
Alzheimers Res Ther; 2021 Dec; 13(1):199. PubMed ID: 34906229
[TBL] [Abstract][Full Text] [Related]
27. Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease.
Mattsson N; Andreasson U; Zetterberg H; Blennow K;
JAMA Neurol; 2017 May; 74(5):557-566. PubMed ID: 28346578
[TBL] [Abstract][Full Text] [Related]
28. Accelerated inflammatory aging in Alzheimer's disease and its relation to amyloid, tau, and cognition.
Cullen NC; Mälarstig AN; Stomrud E; Hansson O; Mattsson-Carlgren N
Sci Rep; 2021 Jan; 11(1):1965. PubMed ID: 33479445
[TBL] [Abstract][Full Text] [Related]
29. Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer's disease.
Gangishetti U; Christina Howell J; Perrin RJ; Louneva N; Watts KD; Kollhoff A; Grossman M; Wolk DA; Shaw LM; Morris JC; Trojanowski JQ; Fagan AM; Arnold SE; Hu WT
Alzheimers Res Ther; 2018 Sep; 10(1):98. PubMed ID: 30253800
[TBL] [Abstract][Full Text] [Related]
30. Plasma amyloid beta 40/42, phosphorylated tau 181, and neurofilament light are associated with cognitive impairment and neuropathological changes among World Trade Center responders: A prospective cohort study of exposures and cognitive aging at midlife.
Kritikos M; Diminich ED; Meliker J; Mielke M; Bennett DA; Finch CE; Gandy SE; Carr MA; Yang X; Kotov R; Kuan PF; Bromet EJ; Clouston SAP; Luft BJ
Alzheimers Dement (Amst); 2023; 15(1):e12409. PubMed ID: 36911360
[TBL] [Abstract][Full Text] [Related]
31. Association of glial and neuronal degeneration markers with Alzheimer's disease cerebrospinal fluid profile and cognitive functions.
Teitsdottir UD; Jonsdottir MK; Lund SH; Darreh-Shori T; Snaedal J; Petersen PH
Alzheimers Res Ther; 2020 Aug; 12(1):92. PubMed ID: 32753068
[TBL] [Abstract][Full Text] [Related]
32. Biomarker-Based Prediction of Longitudinal Tau Positron Emission Tomography in Alzheimer Disease.
Leuzy A; Smith R; Cullen NC; Strandberg O; Vogel JW; Binette AP; Borroni E; Janelidze S; Ohlsson T; Jögi J; Ossenkoppele R; Palmqvist S; Mattsson-Carlgren N; Klein G; Stomrud E; Hansson O
JAMA Neurol; 2022 Feb; 79(2):149-158. PubMed ID: 34928318
[TBL] [Abstract][Full Text] [Related]
33. Progression to dementia in memory clinic patients with mild cognitive impairment and normal β-amyloid.
Rosenberg A; Solomon A; Jelic V; Hagman G; Bogdanovic N; Kivipelto M
Alzheimers Res Ther; 2019 Dec; 11(1):99. PubMed ID: 31805990
[TBL] [Abstract][Full Text] [Related]
34. Amyloid β Deposition and Suspected Non-Alzheimer Pathophysiology and Cognitive Decline Patterns for 12 Years in Oldest Old Participants Without Dementia.
Zhao Y; Tudorascu DL; Lopez OL; Cohen AD; Mathis CA; Aizenstein HJ; Price JC; Kuller LH; Kamboh MI; DeKosky ST; Klunk WE; Snitz BE
JAMA Neurol; 2018 Jan; 75(1):88-96. PubMed ID: 29114732
[TBL] [Abstract][Full Text] [Related]
35. Psychosocial Factors Associated With Accelerated GrimAge in Male U.S. Military Veterans.
Tamman AJF; Nagamatsu S; Krystal JH; Gelernter J; Montalvo-Ortiz JL; Pietrzak RH
Am J Geriatr Psychiatry; 2023 Feb; 31(2):97-109. PubMed ID: 36210262
[TBL] [Abstract][Full Text] [Related]
36. Recalibrating the epigenetic clock after exposure to trauma: The role of risk and protective psychosocial factors.
Mehta D; Bruenig D; Pierce J; Sathyanarayanan A; Stringfellow R; Miller O; Mullens AB; Shakespeare-Finch J
J Psychiatr Res; 2022 May; 149():374-381. PubMed ID: 34823878
[TBL] [Abstract][Full Text] [Related]
37. Plasma Aβ and neurofilament light chain are associated with cognitive and physical function decline in non-dementia older adults.
He L; de Souto Barreto P; Aggarwal G; Nguyen AD; Morley JE; Li Y; Bateman RJ; Vellas B;
Alzheimers Res Ther; 2020 Oct; 12(1):128. PubMed ID: 33032662
[TBL] [Abstract][Full Text] [Related]
38. Interactive Associations of Vascular Risk and β-Amyloid Burden With Cognitive Decline in Clinically Normal Elderly Individuals: Findings From the Harvard Aging Brain Study.
Rabin JS; Schultz AP; Hedden T; Viswanathan A; Marshall GA; Kilpatrick E; Klein H; Buckley RF; Yang HS; Properzi M; Rao V; Kirn DR; Papp KV; Rentz DM; Johnson KA; Sperling RA; Chhatwal JP
JAMA Neurol; 2018 Sep; 75(9):1124-1131. PubMed ID: 29799986
[TBL] [Abstract][Full Text] [Related]
39. Systematic assessment of plasma biomarkers in spinocerebellar ataxia.
Shen XN; Wu KM; Huang YY; Guo Y; Huang SY; Zhang YR; Chen SF; Wang HF; Zhang W; Cheng W; Cui M; Dong Q; Yu JT
Neurobiol Dis; 2023 Jun; 181():106112. PubMed ID: 37003406
[TBL] [Abstract][Full Text] [Related]
40. Methylation of the AIM2 gene: An epigenetic mediator of PTSD-related inflammation and neuropathology plasma biomarkers.
Hawn SE; Neale Z; Wolf EJ; Zhao X; Pierce M; Fein-Schaffer D; Milberg W; McGlinchey R; Logue M; Miller MW
Depress Anxiety; 2022 Apr; 39(4):323-333. PubMed ID: 35312143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
